Farah Nabil; Saleem, M. First-Line FOLFIRINOX Vs Gemcitabine ± Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma: Real-World Treatment Response and Clinicopathologic Predictors from a 2022 Tertiary-Center Cohort. MECOJ 2026, 2 (2), 11-17. https://doi.org/10.61706/MECOJ160191.